Prevent Cancer- Greenville
CCPW
Prevent Cancer-Greenville: A Center for Cancer Prevention and Wellness Research Project
1 other identifier
observational
1,000
1 country
1
Brief Summary
Prevent Cancer-Greenville was created to provide individuals with the opportunity to have their risk of developing cancer studied. Some individuals may be at a higher risk due to their personal lifestyle, family history and/or exposures. If subjects are found to be at high risk for developing a disease, they will be sent to a healthcare provider for further care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2018
CompletedFirst Submitted
Initial submission to the registry
April 29, 2021
CompletedFirst Posted
Study publicly available on registry
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 8, 2029
February 17, 2026
February 1, 2026
10 years
April 29, 2021
February 11, 2026
Conditions
Outcome Measures
Primary Outcomes (10)
Assess changes in nutrition by nutrition questionnaire
Nutrition will be assessed yearly by a questionnaire based on nutrition recommendations from the American Institute for Cancer Research and the U.S. Department of Health and Human Services.
Yearly follow up for 10 years
Assess changes in physical activity by physical activity questionnaire
Physical activity will be assessed yearly a questionnaire based on physical activity recommendations from the U.S. Department of Health and Human Services.
Yearly follow up for 10 years
Assess changes in smoking habits
Participants will be educated on healthy lifestyle habits and smoking habits will be assessed yearly.
Yearly follow up for 10 years
Assess changes in alcohol use
Participants will be educated on healthy lifestyle habits and alcohol use will be assessed yearly.
Yearly follow up for 10 years
Assess hereditary risk through family history review
Each participant's family history will be reviewed to make recommendations for screening or genetic testing based on National Comprehensive Cancer Network guidelines.
Yearly follow up for 10 years
Assess lifetime breast cancer risk through the Tyrer-Cuzick version 8 breast risk evaluation tool
Participants' breast cancer risk will be assessed using the Tyrer-Cuzick breast cancer risk model. Participants will be referred to appropriate clinics if lifetime risk is greater than 20 percent.
Yearly follow up for 10 years
Assess 5- year breast cancer risk through the GAIL breast risk evaluation tool
Participants' breast cancer risk will be assessed using the National Cancer Institute's GAIL model. Participants will be referred to appropriate clinics if GAIL 5 year risk is greater than 1.7 percent.
Yearly follow up for 10 years
Early detection of malignancies through screening
Participants will be educated on screening recommendations by the American Cancer Society. Malignancies will be recorded yearly if found by recommended screenings.
Yearly follow up for 10 years
Assess changes in fat mass by SOZO measurements
Body composition will be assessed yearly by measurements taken from the SOZO device which uses bioimpedance spectroscopy to measure fat mass.
Yearly follow up for 10 years
Assess changes in muscle mass by SOZO measurements
Body composition will be assessed yearly by measurements taken from the SOZO device which uses bioimpedance spectroscopy to measure muscle mass.
Yearly follow up for 10 years
Secondary Outcomes (1)
Assess changes in quality of life by the 5-level EuroQol-5D version (EQ-5D-5L) questionnaire
Yearly follow up for 10 years
Eligibility Criteria
Individuals 18 years or older
You may qualify if:
- years or older
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prisma Health-Upstate
Greenville, South Carolina, 29605, United States
Related Links
Biospecimen
Blood, urine and cheek swab specimens will be collected.
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Joe Stephenson, MD
Prisma Health-Upstate
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2021
First Posted
July 1, 2021
Study Start
November 8, 2018
Primary Completion (Estimated)
November 8, 2028
Study Completion (Estimated)
November 8, 2029
Last Updated
February 17, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
De-identified data sets will be available upon requests following institutional approval.